ELUT
Price
$3.14
Change
+$0.36 (+12.95%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
76.46M
57 days until earnings call
STRR
Price
$2.44
Change
+$0.18 (+7.96%)
Updated
Mar 10, 04:18 PM (EDT)
Capitalization
14.07M
Ad is loading...

ELUT vs STRR

Header iconELUT vs STRR Comparison
Open Charts ELUT vs STRRBanner chart's image
Elutia
Price$3.14
Change+$0.36 (+12.95%)
Volume$1.1K
Capitalization76.46M
Star Equity Holdings
Price$2.44
Change+$0.18 (+7.96%)
Volume$250
Capitalization14.07M
ELUT vs STRR Comparison Chart
Loading...
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELUT vs. STRR commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELUT is a Hold and STRR is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ELUT: $2.78 vs. STRR: $2.26)
Brand notoriety: ELUT and STRR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ELUT: 329% vs. STRR: 31%
Market capitalization -- ELUT: $76.46M vs. STRR: $14.07M
ELUT [@Medical Specialties] is valued at $76.46M. STRR’s [@Medical Specialties] market capitalization is $14.07M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELUT’s FA Score shows that 0 FA rating(s) are green whileSTRR’s FA Score has 1 green FA rating(s).

  • ELUT’s FA Score: 0 green, 5 red.
  • STRR’s FA Score: 1 green, 4 red.
According to our system of comparison, STRR is a better buy in the long-term than ELUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELUT’s TA Score shows that 3 TA indicator(s) are bullish while STRR’s TA Score has 4 bullish TA indicator(s).

  • ELUT’s TA Score: 3 bullish, 4 bearish.
  • STRR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, STRR is a better buy in the short-term than ELUT.

Price Growth

ELUT (@Medical Specialties) experienced а -15.40% price change this week, while STRR (@Medical Specialties) price change was -0.66% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.36%. For the same industry, the average monthly price growth was -7.61%, and the average quarterly price growth was -4.31%.

Reported Earning Dates

ELUT is expected to report earnings on May 07, 2025.

STRR is expected to report earnings on Aug 14, 2024.

Industries' Descriptions

@Medical Specialties (-2.36% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELUT($76.5M) has a higher market cap than STRR($14.1M). STRR YTD gains are higher at: 0.000 vs. ELUT (-25.802). STRR has higher annual earnings (EBITDA): -1.69M vs. ELUT (-31.68M). STRR has more cash in the bank: 23.2M vs. ELUT (19.3M). STRR has less debt than ELUT: STRR (3.61M) vs ELUT (24M). STRR has higher revenues than ELUT: STRR (45.8M) vs ELUT (24.7M).
ELUTSTRRELUT / STRR
Capitalization76.5M14.1M543%
EBITDA-31.68M-1.69M1,878%
Gain YTD-25.8020.000-
P/E RatioN/AN/A-
Revenue24.7M45.8M54%
Total Cash19.3M23.2M83%
Total Debt24M3.61M665%
FUNDAMENTALS RATINGS
STRR: Fundamental Ratings
STRR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELUTSTRR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Ad is loading...
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FENC6.880.07
+1.03%
Fennec Pharmaceuticals
PBA37.860.14
+0.37%
PEMBINA PIPELINE Corp
ZYME12.00-0.13
-1.07%
Zymeworks
CVCO520.32-9.05
-1.71%
Cavco Industries
ATHA0.34-0.01
-2.48%
Athira Pharma

ELUT and

Correlation & Price change

A.I.dvisor tells us that ELUT and RBOT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and RBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELUT
1D Price
Change %
ELUT100%
+8.82%
RBOT - ELUT
31%
Poorly correlated
-0.32%
MHUA - ELUT
29%
Poorly correlated
+2.80%
TWST - ELUT
28%
Poorly correlated
+0.64%
CDNA - ELUT
25%
Poorly correlated
+0.11%
STRRP - ELUT
23%
Poorly correlated
-3.27%
More

STRR and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRR has been closely correlated with CATX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRR jumps, then CATX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRR
1D Price
Change %
STRR100%
+2.73%
CATX - STRR
88%
Closely correlated
-3.33%
NSYS - STRR
29%
Poorly correlated
-2.29%
MASS - STRR
28%
Poorly correlated
-8.31%
INMD - STRR
25%
Poorly correlated
-1.50%
INGN - STRR
23%
Poorly correlated
-0.64%
More